rs397517838
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_138691.3(TMC1):c.2068G>A(p.Ala690Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00000124 in 1,613,952 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_138691.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152152Hom.: 0 Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461800Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 727200
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152152Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74332
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The Ala690Thr varia nt has not been reported in the literature nor previously identified by our labo ratory. This residue is conserved in mammals; however, it is not conserved in ch ickens and computational analyses (PolyPhen, SIFT, AlignGVGD) do not suggest a h igh likelihood of impact to the protein. However, this information is not very p redictive of pathogenicity. It should be noted that this lab has only sequenced the TMC1 in 104 individuals such that the full spectrum of benign variation has not yet been defined for this gene, increasing the possibility that this may be a benign variant. In summary, the clinical significance of this variant cannot b e determined with certainty at this time; however based upon the arguments descr ibed above, we would lean towards a more likely benign role. -
Inborn genetic diseases Uncertain:1
The c.2068G>A (p.A690T) alteration is located in exon 21 (coding exon 17) of the TMC1 gene. This alteration results from a G to A substitution at nucleotide position 2068, causing the alanine (A) at amino acid position 690 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at